Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Sexually Transmitted Diseases

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 130 articles:
HTML format
Text format



Single Articles


    July 2018
  1. MEZA R, Lau YK, Thomas TB, Carey TE, et al
    DNA Concentration from self samples for HPV testing.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31666.
    PubMed     Text format    


    June 2018
  2. GUSTAVSSON I, Aarnio R, Berggrund M, Hedlund-Lindberg J, et al
    Randomized study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel.
    Int J Cancer. 2018 Jun 26. doi: 10.1002/ijc.31637.
    PubMed     Text format     Abstract available


  3. REZHAKE R, Hu SY, Zhao S, Xu XQ, et al
    Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Int J Cancer. 2018 Jun 26. doi: 10.1002/ijc.31633.
    PubMed     Text format     Abstract available


    April 2018
  4. THAMSBORG LH, Napolitano G, Larsen LG, Lynge E, et al
    Impact of HPV-vaccination on outcome of cervical cytology screening in Denmark - a register based cohort study.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31568.
    PubMed     Text format     Abstract available


  5. DE STROOPER LMA, Berkhof J, Steenbergen RDM, Lissenberg-Witte BI, et al
    Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31539.
    PubMed     Text format     Abstract available


    March 2018
  6. VINTERMYR OK, Andersland MS, Bjorge T, Skar R, et al
    Human papillomavirus type specific risk of progression and remission during long term follow-up of equivocal and low grade HPV-positive cervical smears.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31390.
    PubMed     Text format     Abstract available


  7. KELLEN E, Benoy I, Vanden Broeck D, Martens P, et al
    A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31391.
    PubMed     Text format     Abstract available


  8. YU L, Jiang M, Qu P, Wu Z, et al
    Clinical Evaluation of Human Papillomavirus 16/18 Oncoprotein Test for Cervical Cancer Screening and HPV Positive Women Triage.
    Int J Cancer. 2018 Mar 9. doi: 10.1002/ijc.31368.
    PubMed     Text format     Abstract available


    February 2018
  9. DEL MISTRO A, Adcock R, Carozzi F, Gillio-Tos A, et al
    HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.
    Int J Cancer. 2018 Feb 17. doi: 10.1002/ijc.31326.
    PubMed     Text format     Abstract available


  10. RIETBERGEN MM, van Bokhoven AAJD, Lissenberg-Witte BI, Heideman DAM, et al
    Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31315.
    PubMed     Text format     Abstract available


    January 2018
  11. GRAY P, Palmroth J, Luostarinen T, Apter D, et al
    Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females - Post-hoc analysis of a community-randomized clinical trial (II).
    Int J Cancer. 2018 Jan 29. doi: 10.1002/ijc.31281.
    PubMed     Text format     Abstract available


  12. CUSCHIERI K, Ronco G, Lorincz A, Smith L, et al
    Eurogin Roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programmes.
    Int J Cancer. 2018 Jan 17. doi: 10.1002/ijc.31261.
    PubMed     Text format     Abstract available


  13. STEINBACH A, Riemer AB
    Immune evasion mechanisms of human papillomavirus: An update.
    Int J Cancer. 2018;142:224-229.
    PubMed     Text format     Abstract available


  14. MERMOD M, Hiou-Feige A, Bovay E, Roh V, et al
    Mouse model of post-surgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer.
    Int J Cancer. 2018 Jan 4. doi: 10.1002/ijc.31240.
    PubMed     Text format     Abstract available


    December 2017
  15. LUOSTARINEN T, Apter D, Dillner J, Eriksson T, et al
    Vaccination protects against invasive HPV-associated cancers.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31231.
    PubMed     Text format    


  16. ARROYO MUHR LS, Bzhalava Z, Hortlund M, Lagheden C, et al
    Viruses in cancers among the immunosuppressed.
    Int J Cancer. 2017;141:2498-2504.
    PubMed     Text format     Abstract available


  17. GULTEKIN M, Zayifoglu Karaca M, Kucukyildiz I, Dundar S, et al
    Initial results of population based cervical cancer screening program using hpv testing in one million turkish women.
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31212.
    PubMed     Text format     Abstract available


  18. KANG YJ, Smith M, Barlow E, Coffey K, et al
    Vulvar cancer in high-income countries: Increasing burden of disease.
    Int J Cancer. 2017;141:2174-2186.
    PubMed     Text format     Abstract available


    November 2017
  19. RAJENDRA S, Yang T, Xuan W, Sharma P, et al
    Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
    Int J Cancer. 2017;141:2037-2049.
    PubMed     Text format     Abstract available


  20. RASMUSSEN CL, Sand FL, Hoffmann Frederiksen M, Andersen KK, et al
    Does HPV status influence survival after vulvar cancer?
    Int J Cancer. 2017 Nov 1. doi: 10.1002/ijc.31139.
    PubMed     Text format     Abstract available


    October 2017
  21. LANDY R, Windridge P, Gillman MS, Sasieni PD, et al
    What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study.
    Int J Cancer. 2017 Oct 11. doi: 10.1002/ijc.31094.
    PubMed     Text format     Abstract available


  22. ZHU L, Sturgis EM, Zhang H, Lu Z, et al
    Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Int J Cancer. 2017;141:1355-1364.
    PubMed     Text format     Abstract available


    September 2017
  23. FABER MT, Sand FL, Albieri V, Norrild B, et al
    Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva.
    Int J Cancer. 2017;141:1161-1169.
    PubMed     Text format     Abstract available


  24. ZHANG Q, Dong L, Hu S, Feng R, et al
    Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China.
    Int J Cancer. 2017;141:1110-1119.
    PubMed     Text format     Abstract available


    August 2017
  25. RAKISLOVA N, Clavero O, Alemany L, Saco A, et al
    "Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: A study of 1594 cases".
    Int J Cancer. 2017 Aug 17. doi: 10.1002/ijc.31006.
    PubMed     Text format     Abstract available


  26. VASILJEVIC N, Carter PD, Reuter C, Warman R, et al
    Role of quantitative p16INK4A mRNA assay and digital reading of p16INK4A immunostained sections in diagnosis of cervical intraepithelial neoplasia.
    Int J Cancer. 2017;141:829-836.
    PubMed     Text format     Abstract available


  27. CLARKE MA, Luhn P, Gage JC, Bodelon C, et al
    Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
    Int J Cancer. 2017;141:701-710.
    PubMed     Text format     Abstract available


  28. VELENTZIS LS, Caruana M, Simms KT, Lew JB, et al
    How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccina
    Int J Cancer. 2017 Aug 12. doi: 10.1002/ijc.30926.
    PubMed     Text format     Abstract available


    July 2017
  29. KHAN S, Oosterhuis K, Wunderlich K, Bunnik EM, et al
    Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.
    Int J Cancer. 2017;141:393-404.
    PubMed     Text format     Abstract available


  30. BROTHERTON JM, Tabrizi SN, Phillips S, Pyman J, et al
    Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30871.
    PubMed     Text format     Abstract available


  31. VELDHUIJZEN NJ, Polman NJ, Snijders PJF, Meijer CJLM, et al
    Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30865.
    PubMed     Text format     Abstract available


  32. CABEL L, Bidard FC, Servois V, Cacheux W, et al
    HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30863.
    PubMed     Text format     Abstract available


    June 2017
  33. MATSUMOTO K, Yaegashi N, Iwata T, Yamamoto K, et al
    Early impact of the Japanese immunization program implemented before the HPV vaccination crisis.
    Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30855.
    PubMed     Text format    


  34. HOLZINGER D, Wichmann G, Baboci L, Michel A, et al
    Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2017;140:2748-2757.
    PubMed     Text format     Abstract available


  35. BOSCOLO-RIZZO P, Dietz A
    The AJCC/UICC eighth edition for staging head and neck cancers: Is it wise to de-escalate treatment regimens in p16-positive oropharyngeal cancer patients?
    Int J Cancer. 2017 Jun 14. doi: 10.1002/ijc.30837.
    PubMed     Text format    


    May 2017
  36. LAM JU, Rebolj M, Moller Ejegod D, Pedersen H, et al
    Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms.
    Int J Cancer. 2017;140:2212-2219.
    PubMed     Text format     Abstract available


  37. LOPES RDVC, Teixeira JA, Marchioni D, Villa LL, et al
    Dietary intake of selected nutrients and persistence of HPV infection in men.
    Int J Cancer. 2017 May 9. doi: 10.1002/ijc.30772.
    PubMed     Text format     Abstract available


  38. BALERMPAS P, Rodel F, Krause M, Linge A, et al
    The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Int J Cancer. 2017 May 8. doi: 10.1002/ijc.30770.
    PubMed     Text format     Abstract available


  39. AGORASTOS T, Chatzistamatiou K, Moysiadis T, Kaufmann AM, et al
    Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study.
    Int J Cancer. 2017 May 3. doi: 10.1002/ijc.30761.
    PubMed     Text format    


  40. SHEN C, Liu Y, Shi S, Zhang R, et al
    Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region up-regulating the allele-specific MYC expression in HeLa cells.
    Int J Cancer. 2017 May 3. doi: 10.1002/ijc.30763.
    PubMed     Text format     Abstract available


  41. NICOLAS-PARRAGA S, Alemany L, de Sanjose S, Bosch FX, et al
    Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma.
    Int J Cancer. 2017;140:2092-2100.
    PubMed     Text format     Abstract available


    April 2017
  42. RYSER M, Guignard A, Taylor S
    Letter to the Editor in response to Herweijer E., Sundstrom K., Ploner A., Uhnoo I., Sparen P. and Arnheim-Dahlstrom L. (2016), Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.
    Int J Cancer. 2017 Apr 29. doi: 10.1002/ijc.30753.
    PubMed     Text format    


  43. FU XI L, Schiffman M, Ke Y, Hughes JP, et al
    Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.
    Int J Cancer. 2017;140:1747-1756.
    PubMed     Text format     Abstract available


  44. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    PubMed     Text format     Abstract available


    March 2017
  45. GHEIT T, Anantharaman D, Holzinger D, Alemany L, et al
    Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
    Int J Cancer. 2017 Mar 29. doi: 10.1002/ijc.30712.
    PubMed     Text format     Abstract available


  46. CHEOL PARK G, Roh JL, Cho KJ, Seung Kim J, et al
    18 F-FDG PET/CT vs. human papillomavirus, p16 and Epstein-Barr virus detection in cervical metastatic lymph nodes for identifying primary tumors.
    Int J Cancer. 2017;140:1405-1412.
    PubMed     Text format     Abstract available


  47. MEZEI AK, Armstrong HL, Pedersen HN, Campos NG, et al
    Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: a systematic review.
    Int J Cancer. 2017 Mar 15. doi: 10.1002/ijc.30695.
    PubMed     Text format     Abstract available


  48. DAS GHOSH D, Mukhopadhyay I, Bhattacharya A, Roy Chowdhury R, et al
    Impact of genetic variations and transcriptional alterations of HLA class I genes on cervical cancer pathogenesis.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30681.
    PubMed     Text format     Abstract available


  49. PRIGGE ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M, et al
    Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2017;140:1186-1198.
    PubMed     Text format     Abstract available


  50. SCHNELLE C, Whiteman DC, Porceddu SV, Panizza BJ, et al
    Past sexual behaviors and risks of oropharyngeal squamous cell carcinoma: a case-case comparison.
    Int J Cancer. 2017;140:1027-1034.
    PubMed     Text format     Abstract available


    February 2017
  51. JEHANNIN-LIGIER K, Belot A, Guizard AV, Bossard N, et al
    Incidence Trends for Potentially Human Papilloma Virus-Related and -Unrelated Head and Neck Cancers in France using Population-based Cancer Registries Data: 1980-2012.
    Int J Cancer. 2017 Feb 6. doi: 10.1002/ijc.30631.
    PubMed     Text format     Abstract available


  52. LIEDERBACH E, Kyrillos A, Wang CH, Liu JC, et al
    The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Int J Cancer. 2017;140:504-512.
    PubMed     Text format     Abstract available


    January 2017
  53. HOFFMAN SR, Le T, Lockhart A, Sanusi A, et al
    Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30623.
    PubMed     Text format    


  54. RODRIGUEZ AC, Avila C, Herrero R, Hildesheim A, et al
    Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-year follow-up of the Guanacaste cohort.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30614.
    PubMed     Text format     Abstract available


  55. MITTAL S, Basu P, Muwonge R, Banerjee D, et al
    Risk of high grade precancerous lesions and invasive cancers in high risk HPV positive women with normal cervix or CIN 1 at baseline - a population based cohort study.
    Int J Cancer. 2017 Jan 20. doi: 10.1002/ijc.30609.
    PubMed     Text format     Abstract available


  56. ANANTHARAMAN D, Abedi-Ardekani B, Beachler DC, Gheit T, et al
    Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer.
    Int J Cancer. 2017 Jan 20. doi: 10.1002/ijc.30608.
    PubMed     Text format     Abstract available


  57. POLMAN NJ, Uijterwaal MH, Witte BI, Berkhof J, et al
    Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.
    Int J Cancer. 2017;140:423-430.
    PubMed     Text format     Abstract available


    December 2016
  58. WENTZENSEN N, Arbyn M, Berkhof J, Bower M, et al
    Eurogin 2016 Roadmap: How HPV knowledge is changing screening practice.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30579.
    PubMed     Text format     Abstract available


  59. HATANO T, Sano D, Takahashi H, Hyakusoku H, et al
    Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30589.
    PubMed     Text format     Abstract available


  60. BOGANI G, Chiappa V, Martinelli F, Raspagliesi F, et al
    Type-Specific HPV Infection Correlates with Risk of Recurrence of Vulvar Intraepithelial Neoplasia Usual Type.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30585.
    PubMed     Text format    


  61. CHEN W, Molijn A, Enqi W, Zhang X, et al
    The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China.
    Int J Cancer. 2016;139:2687-2697.
    PubMed     Text format     Abstract available


  62. CAMPOS NG, Tsu V, Jeronimo J, Mvundura M, et al
    To Expand Coverage, or Increase Frequency: Quantifying the Tradeoffs between Equity and Efficiency Facing Cervical Cancer Screening Programs in Low-Resource Settings.
    Int J Cancer. 2016 Dec 7. doi: 10.1002/ijc.30551.
    PubMed     Text format     Abstract available


    November 2016
  63. KOCSIS A, Takacs T, Jeney C, Schaff Z, et al
    Performance of a New HPV and Biomarker Assay in Management of hrHPV Positive Women: Subanalysis of the Ongoing Multicenter TRACE Clinical Trial (n>6,000) to Evaluate POU4F3 as a Potential Biomarker of Cervical Precancer and Cancer.
    Int J Cancer. 2016 Nov 22. doi: 10.1002/ijc.30534.
    PubMed     Text format     Abstract available


  64. WAKEHAM K, Kavanagh K, Cuschieri K, Millan D, et al
    HPV status and favorable outcome in vulvar squamous cancer.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30523.
    PubMed     Text format     Abstract available


  65. FU TC, Carter JJ, Hughes JP, Feng Q, et al
    Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.
    Int J Cancer. 2016;139:2201-12.
    PubMed     Text format     Abstract available


  66. TAINIO K, Jakobsson M, Louvanto K, Kalliala I, et al
    Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management.
    Int J Cancer. 2016;139:2353-8.
    PubMed     Text format     Abstract available


    October 2016
  67. HOLT HK, Zhang L, Zhao FH, Hu SY, et al
    Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.
    Int J Cancer. 2016 Oct 11. doi: 10.1002/ijc.30468.
    PubMed     Text format     Abstract available


  68. SCHIFFMAN M, Yu K, Zuna R, Terence Dunn S, et al
    Proof-of-principle study of a novel cervical screening and triage strategy: computer-analyzed cytology to decide which HPV-positive women are likely to have >/=CIN2.
    Int J Cancer. 2016 Oct 1. doi: 10.1002/ijc.30456.
    PubMed     Text format     Abstract available


    September 2016
  69. OGILVIE GS, Krajden M, van Niekerk D, Smith LW, et al
    HPV For Cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid based cytology for cervical cancer.
    Int J Cancer. 2016 Sep 29. doi: 10.1002/ijc.30454.
    PubMed     Text format     Abstract available


  70. SUDENGA SL, Nelson Torres B, Fulp WJ, Silva R, et al
    Country-Specific HPV-related Genital Disease Among Men Residing in Brazil, Mexico, and the United States: The HIM Study.
    Int J Cancer. 2016 Sep 28. doi: 10.1002/ijc.30452.
    PubMed     Text format     Abstract available


  71. KYRGIOU M, Kalliala I, Mitra A, Ng KY, et al
    Immediate referral to colposcopy vs. cytological surveillance for low-grade cervical cytological abnormalities in the absence of HPV test: A systematic review and a meta-analysis of the literature.
    Int J Cancer. 2016 Sep 7. doi: 10.1002/ijc.30419.
    PubMed     Text format     Abstract available


  72. XI LF, Schiffman M, Koutsky LA, Hughes JP, et al
    Variant-specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia.
    Int J Cancer. 2016;139:1098-105.
    PubMed     Text format     Abstract available


    August 2016
  73. SIMMS KT, Smith MA, Lew JB, Kitchener HC, et al
    Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.
    Int J Cancer. 2016 Aug 19. doi: 10.1002/ijc.30392.
    PubMed     Text format     Abstract available


  74. GARLAND SM, Paavonen J, Jaisamrarn U, Naud P, et al
    Prior human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomised controlled trial.
    Int J Cancer. 2016 Aug 19. doi: 10.1002/ijc.30391.
    PubMed     Text format     Abstract available


  75. GARNAES E, Frederiksen K, Kiss K, Andersen L, et al
    Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30389.
    PubMed     Text format     Abstract available


  76. ISIDEAN SD, Mayrand MH, Ramanakumar AV, Gilbert L, et al
    Human Papillomavirus Testing versus Cytology in Primary Cervical Cancer Screening: End-of-Study and Extended Follow-Up Results from the Canadian Cervical Cancer Screening Trial (CCCaST).
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30385.
    PubMed     Text format     Abstract available


  77. SCHIFFMAN M, Hyun N, Raine-Bennett TR, Katki H, et al
    A Cohort Study of Cervical Screening Using Partial HPV Typing and Cytology Triage.
    Int J Cancer. 2016 Aug 10. doi: 10.1002/ijc.30375.
    PubMed     Text format     Abstract available


  78. ZOU H, Tabrizi SN, Grulich AE, Hocking JS, et al
    Antibody responses following incident anal and penile infection with human papillomavirus in teenage men who have sex with men.
    Int J Cancer. 2016;139:639-46.
    PubMed     Text format     Abstract available


    July 2016
  79. GUO T, Gaykalova DA, Considine M, Wheelan S, et al
    Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;139:373-82.
    PubMed     Text format     Abstract available


  80. VON KNEBEL DOEBERITZ M
    The causal role of human papillomavirus infections in non-anogenital cancers. It's time to ask for the functional evidence.
    Int J Cancer. 2016;139:9-11.
    PubMed     Text format    


    June 2016
  81. BODELON C, Untereiner ME, Machiela MJ, Vinokurova S, et al
    Genomic characterization of viral integration sites in HPV-related cancers.
    Int J Cancer. 2016 Jun 25. doi: 10.1002/ijc.30243.
    PubMed     Text format     Abstract available


  82. DEPUYDT CE, Thys S, Beert J, Jonckheere J, et al
    Linear viral load increase of a single HPV-type in women with multiple HPV infections predicts progression to cervical cancer.
    Int J Cancer. 2016 Jun 24. doi: 10.1002/ijc.30238.
    PubMed     Text format     Abstract available


  83. ZHAO FH, Hu SY, Zhang Q, Zhang X, et al
    Risk assessment to guide cervical screening strategies in a large Chinese population.
    Int J Cancer. 2016;138:2639-47.
    PubMed     Text format     Abstract available


    May 2016
  84. CARLANDER C, Wagner P, Svedhem V, Elfgren K, et al
    Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden.
    Int J Cancer. 2016 May 13. doi: 10.1002/ijc.30188.
    PubMed     Text format     Abstract available


  85. WAGNER S, Wittekindt C, Reuschenbach M, Hennig B, et al
    CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;138:2263-73.
    PubMed     Text format     Abstract available


    April 2016
  86. TANG A, Dadaglio G, Oberkampf M, Di Carlo S, et al
    B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer.
    Int J Cancer. 2016 Apr 30. doi: 10.1002/ijc.30169.
    PubMed     Text format     Abstract available


    March 2016
  87. FRANCESCHI S, Umulisa MC, Tshomo U, Gheit T, et al
    Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.
    Int J Cancer. 2016 Mar 17. doi: 10.1002/ijc.30092.
    PubMed     Text format     Abstract available


  88. EBISCH RM, de Kuyper-de Ridder GM, Bosgraaf RP, Massuger LF, et al
    The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.
    Int J Cancer. 2016 Mar 17. doi: 10.1002/ijc.30090.
    PubMed     Text format     Abstract available


    February 2016
  89. BROTHERTON JM, Jit M, Gravitt PE, Brisson M, et al
    Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30063.
    PubMed     Text format     Abstract available


  90. KINES RC, Cerio RJ, Roberts JN, Thompson CD, et al
    Human papillomavirus capsids preferentially bind and infect tumor cells.
    Int J Cancer. 2016;138:901-11.
    PubMed     Text format     Abstract available


  91. HERWEIJER E, Sundstrom K, Ploner A, Uhnoo I, et al
    Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.
    Int J Cancer. 2016 Feb 9. doi: 10.1002/ijc.30035.
    PubMed     Text format     Abstract available


  92. PETRY KU, Cox JT, Johnson K, Quint W, et al
    Evaluating HPV negative CIN2+ in the ATHENA trial.
    Int J Cancer. 2016 Feb 6. doi: 10.1002/ijc.30032.
    PubMed     Text format     Abstract available


  93. SULTANA F, English DR, Simpson JA, Drennan KT, et al
    Home-based HPV self-sampling improves participation by never- and under-screened women: Results from a large randomised trial (iPap) in Australia.
    Int J Cancer. 2016 Feb 6. doi: 10.1002/ijc.30031.
    PubMed     Text format     Abstract available


  94. BHATIA R, Kavanagh K, Cubie H, Serrano I, et al
    Use of HPV testing for cervical screening in vaccinated women - insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study.
    Int J Cancer. 2016 Feb 4. doi: 10.1002/ijc.30030.
    PubMed     Text format     Abstract available


  95. WANG HM, Cheng NM, Lee LY, Fang YH, et al
    Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
    Int J Cancer. 2016;138:731-8.
    PubMed     Text format     Abstract available


    January 2016
  96. LORINCZ AT, Brentnall AR, Scibior-Bentkowska D, Reuter C, et al
    Validation of a DNA methylation HPV triage classifier in a screening sample.
    Int J Cancer. 2016 Jan 20. doi: 10.1002/ijc.30008.
    PubMed     Text format     Abstract available


  97. MOLIJN A, Jenkins D, Chen W, Zhang X, et al
    The complex relationship between human papillomavirus and cervical adenocarcinoma.
    Int J Cancer. 2016;138:409-16.
    PubMed     Text format     Abstract available


  98. VOJTECHOVA Z, Sabol I, Salakova M, Turek L, et al
    Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis.
    Int J Cancer. 2016;138:386-95.
    PubMed     Text format     Abstract available


  99. STENSEN S, Kjaer SK, Jensen SM, Frederiksen K, et al
    Factors associated with type-specific persistence of high-risk human papillomavirus infection: A population-based study.
    Int J Cancer. 2016;138:361-8.
    PubMed     Text format     Abstract available


  100. VAN BAARS R, van der Marel J, Snijders PJ, Rodriquez-Manfredi A, et al
    CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.
    Int J Cancer. 2016;138:463-71.
    PubMed     Text format     Abstract available


  101. WANGSA D, Chowdhury SA, Ryott M, Gertz EM, et al
    Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.
    Int J Cancer. 2016;138:98-109.
    PubMed     Text format     Abstract available


    December 2015
  102. SKINNER SR, Wheeler CM, Romanowski B, Castellsague X, et al
    Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.
    Int J Cancer. 2015 Dec 19. doi: 10.1002/ijc.29971.
    PubMed     Text format     Abstract available


  103. FRANCESCHI S, Combes JD, Dalstein V, Caudroy S, et al
    Deep brush-based cytology in tonsils resected for benign diseases.
    Int J Cancer. 2015;137:2994-9.
    PubMed     Text format     Abstract available


  104. HOLL K, Nowakowski AM, Powell N, McCluggage WG, et al
    Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.
    Int J Cancer. 2015;137:2858-68.
    PubMed     Text format     Abstract available


  105. HAMMER A, Rositch A, Qeadan F, Gravitt PE, et al
    Age-specific prevalence of HPV16/18 genotypes in cervical cancer: a systematic review and meta-analysis.
    Int J Cancer. 2015 Dec 13. doi: 10.1002/ijc.29959.
    PubMed     Text format     Abstract available


    November 2015
  106. ZHANG F, Sturgis EM, Sun Y, Zhang Y, et al
    Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
    Int J Cancer. 2015;137:2454-61.
    PubMed     Text format     Abstract available


  107. FU TC, Fu Xi L, Hulbert A, Hughes JP, et al
    Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.
    Int J Cancer. 2015;137:2432-42.
    PubMed     Text format     Abstract available


  108. REICH O, Regauer S
    Two major pathways of recurrent high-grade squamous intraepithelial lesions of the cervix.
    Int J Cancer. 2015;137:2520-1.
    PubMed     Text format    


  109. HERFS M, Crum CP
    Response to "Two major pathways of recurrent high-grade squamous intraepithelial lesions of the cervix".
    Int J Cancer. 2015;137:2522-3.
    PubMed     Text format    


  110. CLIFFORD GM, Franceschi S, Keiser O, Schoni-Affolter F, et al
    Immunodeficiency and the risk of cervical intra-epithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV Cohort Study.
    Int J Cancer. 2015 Nov 4. doi: 10.1002/ijc.29913.
    PubMed     Text format     Abstract available


  111. HALEC G, Schmitt M, Egger S, Abnet CC, et al
    Mucosal Alpha-Papillomaviruses are not associated with Esophageal Squamous Cell Carcinomas: Lack of Mechanistic Evidence from South Africa, China and Iran and from a World-Wide Meta-Analysis.
    Int J Cancer. 2015 Nov 3. doi: 10.1002/ijc.29911.
    PubMed     Text format     Abstract available


    September 2015
  112. VALDEZ M, Jeronimo J, Bansil P, Qiao YL, et al
    Effectiveness of novel, lower-cost molecular human papillomavirus-based tests for cervical cancer screening in rural China.
    Int J Cancer. 2015 Sep 30. doi: 10.1002/ijc.29877.
    PubMed     Text format     Abstract available


  113. ZHANG R, Shen C, Zhao L, Wang J, et al
    Dysregulation of host cellular genes targeted by HPV integration contributes to HPV related cervical carcinogenesis.
    Int J Cancer. 2015 Sep 29. doi: 10.1002/ijc.29872.
    PubMed     Text format     Abstract available


    August 2015
  114. LUTTMER R, De Strooper LM, Berkhof J, Snijders PJ, et al
    Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
    Int J Cancer. 2015 Aug 28. doi: 10.1002/ijc.29824.
    PubMed     Text format     Abstract available


  115. LAPRISE C, Mathadil SA, Allison P, Abraham P, et al
    No role for human papillomavirus infection in oral cancers in a region in Southern India.
    Int J Cancer. 2015 Aug 28. doi: 10.1002/ijc.29827.
    PubMed     Text format     Abstract available


  116. CHUNG TK, Van Hummelen P, Chan PK, Cheung TH, et al
    Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women.
    Int J Cancer. 2015;137:776-83.
    PubMed     Text format     Abstract available


    July 2015
  117. HEIDENREICH R, Jasny E, Kowalczyk A, Lutz J, et al
    A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.
    Int J Cancer. 2015;137:372-84.
    PubMed     Text format     Abstract available


  118. BALERMPAS P, Rodel F, Rodel C, Krause M, et al
    CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29683.
    PubMed     Text format     Abstract available


  119. GOSVIG CF, Huusom LD, Andersen KK, Duun-Henriksen AK, et al
    Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization.
    Int J Cancer. 2015 Jul 2. doi: 10.1002/ijc.29673.
    PubMed     Text format     Abstract available


  120. THOMSEN LT, Frederiksen K, Munk C, Junge J, et al
    Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.
    Int J Cancer. 2015;137:193-203.
    PubMed     Text format     Abstract available


  121. RANIERI D, Belleudi F, Magenta A, Torrisi MR, et al
    HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition.
    Int J Cancer. 2015;137:61-72.
    PubMed     Text format     Abstract available


    June 2015
  122. WICHMANN G, Rosolowski M, Krohn K, Kreuz M, et al
    The role of HPV RNA transcription, immune response- related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.
    Int J Cancer. 2015 Jun 20. doi: 10.1002/ijc.29649.
    PubMed     Text format     Abstract available


  123. CUZICK J, Myers O, Hunt WC, Saslow D, et al
    Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management.
    Int J Cancer. 2015;136:2854-63.
    PubMed     Text format     Abstract available


  124. HOLLOWAY A, Simmonds M, Azad A, Fox JL, et al
    Resistance to UV-induced apoptosis by beta-HPV5 E6 involves targeting of activated BAK for proteolysis by recruitment of the HERC1 ubiquitin ligase.
    Int J Cancer. 2015;136:2831-43.
    PubMed     Text format     Abstract available


  125. BERGERON C, Ronco G, Reuschenbach M, Wentzensen N, et al
    The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments.
    Int J Cancer. 2015;136:2741-51.
    PubMed     Text format     Abstract available


    May 2015
  126. CAMPOS NG, Castle PE, Wright TC, Kim JJ, et al
    Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
    Int J Cancer. 2015 May 5. doi: 10.1002/ijc.29594.
    PubMed     Text format     Abstract available


    April 2015
  127. LONNBERG S, Hansen BT, Haldorsen T, Campbell S, et al
    Cervical cancer prevented by screening: Long-term incidence trends by morphology in Norway.
    Int J Cancer. 2015 Apr 1. doi: 10.1002/ijc.29541.
    PubMed     Text format     Abstract available


    November 2014
  128. KLINGHAMMER K, Raguse JD, Plath T, Albers AE, et al
    A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.
    Int J Cancer. 2014 Nov 18. doi: 10.1002/ijc.29344.
    PubMed     Text format     Abstract available


  129. HWANG TZ, Hsiao JR, Tsai CR, Chang JS, et al
    Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009.
    Int J Cancer. 2014 Nov 14. doi: 10.1002/ijc.29330.
    PubMed     Text format     Abstract available


    September 2014
  130. CHEN H, Chen XZ, Waterboer T, Castro FA, et al
    Viral infections and colorectal cancer: A systematic review of epidemiological studies.
    Int J Cancer. 2014 Sep 4. doi: 10.1002/ijc.29180.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: